Tu2018 Rectal Compliance, Acclimation, and Bowel Symptoms in Women With Irritable Bowel Syndrome (IBS)

2012 ◽  
Vol 142 (5) ◽  
pp. S-902-S-903
Author(s):  
Sagar R. Shroff ◽  
C. Prakash Gyawali ◽  
Amir Sabzpoushan ◽  
Navya D. Kanuri ◽  
Billy D. Nix ◽  
...  
2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Martin Aasbrenn ◽  
Stian Lydersen ◽  
Per G. Farup

Background. Irritable bowel syndrome (IBS) is common in subjects with morbid obesity; the effect of weight loss programs on bowel symptoms is largely unknown. Methods. This prospective cohort study explored bowel symptoms, health scores, and biomarkers in subjects with morbid obesity during a six-month-long conservative weight loss intervention. Bowel symptoms were assessed with IBS-severity scoring system (IBS-SSS) and Gastrointestinal Symptom Rating Scale-IBS. Changes in all variables and associations between the changes in bowel symptoms and the other variables were analysed. Results. Eighty-eight subjects (81% females) were included. Body mass index was reduced from 42.0 (3.6) to 38.7 (3.5) (p<0.001). IBS-SSS was reduced from 116 (104) to 81 (84) (p=0.001). In all, 19 out of 25 variables improved significantly. In subjects with and without IBS at inclusion, the improvement in IBS-SSS was 88 (95% CI 55 to 121) and 10 (95% CI −9 to 29), respectively. Improved bowel symptoms were associated with improved subjective well-being, sense of humour, and vitamin D and negatively associated with reduced body mass index. Conclusion. Body mass index and health scores improved during a conservative weight loss intervention. Subjects with IBS before the intervention had a clinically significant improvement in bowel symptoms.


2000 ◽  
Vol 34 (2) ◽  
pp. 300-309 ◽  
Author(s):  
Philip Boyce ◽  
Jemma Gilchrist ◽  
Nicholas J. Talley ◽  
Donna Rose

Objective: The irritable bowel syndrome (IBS) is a chronic and often disabling functional bowel disorder. Psychological treatments, in particular cognitive and behavioural interventions, have been shown to be effective for this disorder. The aim of this study was to test the efficacy of a cognitive-behaviour program. Method: Eight participants (seven female, one male) aged between 24 and 71 years, with a diagnosis of IBS according to the Rome criteria, were recruited from among the gastroenterology outpatients at Nepean Hospital, in Sydney, Australia. Participants were administered pretreatment on measures of psychological function and bowel symptom severity. Following a 2-week baseline period, participants began a structured psychological treatment comprising eight sessions of cognitive-behaviour therapy. Throughout treatment, participants maintained daily records of symptom severity and completed homework assignments to ensure treatment compliance. The pretreatment assessment measures were repeated 1 week post-treatment. Results: After treatment, five of the eight patients no longer met the Rome diagnostic criteria for IBS. There was no significant reduction in bowel symptom frequency. There were, however, significant improvements in the distress and disability associated with bowel symptoms. Anxiety and depression were also significantly reduced. Conclusions: Cognitive-behaviour therapy reduced the distress and disability associated with IBS, but not the frequency of bowel symptoms. This supports the proposed cognitive model for IBS, and cognitive-behaviour therapy appears to have its effect by altering the cognitive response to visceral hypersensitivity.


1988 ◽  
Vol 81 (12) ◽  
pp. 718-720 ◽  
Author(s):  
D Waxman

The irritable bowel syndrome is discussed together with some of its theories, methods of investigation and various treatment regimens. Eight case histories are reported. In each patient, symptoms appeared to be precipitated by situations interpreted by that patient as stressful. A programme of prospective desensitization using hypnosis is described. Where symptoms of depression were additionally present, antidepressant medication was prescribed. This was subsequently phased out as and when indicated. Where patients had been taking antidiarrhoeal or antispasmodic drugs, various stool bulking agents or benzodiazepines, these were also slowly discontinued as treatment progressed. Cases were followed up from 3 months to 12 years. In 2 cases recurrence of symptoms was again successfully treated. There was no recurrence of any of the bowel symptoms in any other patient. The results support the view that the irritable bowel syndrome is psychogenic in origin.


2013 ◽  
Vol 144 (5) ◽  
pp. S-915 ◽  
Author(s):  
Andrea Shin ◽  
Michael Camilleri ◽  
Irene A. Busciglio ◽  
Duane D. Burton ◽  
Priya Vijayvargiya ◽  
...  

2013 ◽  
Vol 144 (5) ◽  
pp. S-728-S-729 ◽  
Author(s):  
Michael Camilleri ◽  
Anthony Lembo ◽  
Bernard J. Lavins ◽  
James E. MacDougall ◽  
Steven J. Shiff ◽  
...  

1998 ◽  
Vol 114 ◽  
pp. A782 ◽  
Author(s):  
J. Kuyvenhoven ◽  
P.J. van der Schaar ◽  
C.B.H.W. Lamers ◽  
A.A.M. Masclee

Sign in / Sign up

Export Citation Format

Share Document